Infectious Diseases
Name | Preis | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Polyclonal Antibody to Interleukin 1 Beta (IL1b) | Anmelden | Polyclonal Antibody to Interleukin 1 Beta (IL1b) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Interleukin 7 (IL7) | Anmelden | Polyclonal Antibody to Interleukin 7 (IL7) | ||||||||||||||||
|
||||||||||||||||||
FITC-Linked Monoclonal Antibody to Interleukin 8 (IL8) | Anmelden | FITC-Linked Monoclonal Antibody to Interleukin 8 (IL8) | ||||||||||||||||
|
||||||||||||||||||
FITC-Linked Monoclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1) | Anmelden | FITC-Linked Monoclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1) | ||||||||||||||||
|
||||||||||||||||||
Biotin-Linked Monoclonal Antibody to Interleukin 8 (IL8) | Anmelden | Biotin-Linked Monoclonal Antibody to Interleukin 8 (IL8) | ||||||||||||||||
|
||||||||||||||||||
Biotin-Linked Monoclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1) | Anmelden | Biotin-Linked Monoclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Fusion (FUS) | Anmelden | Polyclonal Antibody to Fusion (FUS) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Fusion (FUS) | Anmelden | Polyclonal Antibody to Fusion (FUS) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Fusion (FUS) | Anmelden | Polyclonal Antibody to Fusion (FUS) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Dyskerin (DKC) | Anmelden | Polyclonal Antibody to Dyskerin (DKC) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Dyskerin (DKC) | Anmelden | Polyclonal Antibody to Dyskerin (DKC) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Dyskerin (DKC) | Anmelden | Polyclonal Antibody to Dyskerin (DKC) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Heterogeneous Nuclear Ribonucleoprotein A1 (HNRNPA1) | Anmelden | Polyclonal Antibody to Heterogeneous Nuclear Ribonucleoprotein A1 (HNRNPA1) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Heterogeneous Nuclear Ribonucleoprotein A1 (HNRNPA1) | Anmelden | Polyclonal Antibody to Heterogeneous Nuclear Ribonucleoprotein A1 (HNRNPA1) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Polypyrimidine Tract Binding Protein 1 (PTBP1) | Anmelden | Polyclonal Antibody to Polypyrimidine Tract Binding Protein 1 (PTBP1) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Poly U Binding Splicing Factor 60kDa (PUF60) | Anmelden | Polyclonal Antibody to Poly U Binding Splicing Factor 60kDa (PUF60) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Sjogren Syndrome Antigen A2 (SSA2) | Anmelden | Polyclonal Antibody to Sjogren Syndrome Antigen A2 (SSA2) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Sjogren Syndrome Antigen A2 (SSA2) | Anmelden | Polyclonal Antibody to Sjogren Syndrome Antigen A2 (SSA2) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Sjogren Syndrome Antigen A1 (SSA1) | Anmelden | Polyclonal Antibody to Sjogren Syndrome Antigen A1 (SSA1) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Sjogren Syndrome Antigen A1 (SSA1) | Anmelden | Polyclonal Antibody to Sjogren Syndrome Antigen A1 (SSA1) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Sjogren Syndrome Antigen B (SSB) | Anmelden | Polyclonal Antibody to Sjogren Syndrome Antigen B (SSB) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Sjogren Syndrome Antigen B (SSB) | Anmelden | Polyclonal Antibody to Sjogren Syndrome Antigen B (SSB) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Vitronectin (VTN) | Anmelden | Polyclonal Antibody to Vitronectin (VTN) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Vitronectin (VTN) | Anmelden | Polyclonal Antibody to Vitronectin (VTN) | ||||||||||||||||
|
||||||||||||||||||
Polyclonal Antibody to Vitronectin (VTN) | Anmelden | Polyclonal Antibody to Vitronectin (VTN) | ||||||||||||||||
|